Literature DB >> 19870195

VARYING HEMOLYTIC AND CONSTANT COMBINING CAPACITY OF STREPTOLYSINS; INFLUENCE ON TESTING FOR ANTISTREPTOLYSINS.

B E Hodge1, H F Swift.   

Abstract

Certain properties of streptolysin in respect of hemolytic power and capacity for combining with antistreptolysins have been determined. The hemolytic strength may vary markedly, while under suitable conditions the combining power is constant. This stability of combining capacity makes it possible to prepare a large amount of streptolysin, standardize it against sera of known antistreptolysin strength, and use it as a reagent over a considerable period for testing the antistreptolysin content of unknown sera. A modified technique for making these tests is described.

Year:  1933        PMID: 19870195      PMCID: PMC2132299          DOI: 10.1084/jem.58.3.277

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  2 in total

1.  STUDIES ON THE OXIDATION AND REDUCTION OF IMMUNOLOGICAL SUBSTANCES : IV. STREPTOLYSIN.

Authors:  J M Neill; T B Mallory
Journal:  J Exp Med       Date:  1926-07-31       Impact factor: 14.307

2.  ANTIGENIC STREPTOCOCCAL HEMOLYSIN.

Authors:  E W Todd
Journal:  J Exp Med       Date:  1932-01-31       Impact factor: 14.307

  2 in total
  6 in total

1.  Antistreptolysin-O: its interaction with streptolysin-O, its titration and a comparison of some standard preparations.

Authors:  H GOODER
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

2.  International Standard for Antistreptolysin-O.

Authors:  J Spaun; M W Bentzon; S O Larsen; L F Hewitt
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

3.  The anatomical area of involvement in streptococcal infections and the carrier state.

Authors:  R W Quinn; P N Lowry
Journal:  Yale J Biol Med       Date:  1970-08

4.  The experimental induction of glomerulonephritis like that in man by infection with group A streptococci.

Authors:  C G Becker; G E Murphy
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

5.  STUDIES ON STREPTOCOCCAL FIBRINOLYSIS : V. THE IN VITRO PRODUCTION OF FIBRINOLYSIN BY VARIOUS GROUPS AND TYPES OF BETA HEMOLYTIC STREPTOCOCCI; RELATIONSHIP TO ANTIFIBRINOLYSIN PRODUCTION.

Authors: 
Journal:  J Exp Med       Date:  1947-04-30       Impact factor: 14.307

6.  TYPE-SPECIFIC PROTECTION AND IMMUNITY FOLLOWING INTRANASAL INOCULATION OF MONKEYS WITH GROUP A HEMOLYTIC STREPTOCOCCI.

Authors:  R F Watson; S Rothbard; H F Swift
Journal:  J Exp Med       Date:  1946-07-31       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.